等待开盘 09-20 09:30:00 美东时间
+0.034
+5.18%
Top Wall Street analysts changed their outlook on these top names. For a comple...
08-27 21:01
Maxim Group analyst Jason McCarthy downgrades Cyclo Therapeutics (NASDAQ:CYTH) from Buy to Hold.
08-27 20:32
NEW YORK, Aug. 26, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may see...
08-26 21:37
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-23 19:20
Cyclo Therapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy
08-23 18:02
Cyclo Therapeutics Shares Down 28.6% at $0.90 After Merger Agreement With Rafae...
08-22 21:35
Rafael Holdings (NYSE:RFL) to combine with Cyclo Therapeutics (NASDAQ:CYTH) to focus on the development of Trappsol Cyclo for the treatment of Niemann-Pick Disease Type C1. Cyclo Therapeutics (CYTH) d...
08-22 19:27
Rafael Holdings: Proposed Deal for Cyclo Therapeutics Shares at $0.95 per Share
08-22 18:52
Cyclo Therapeutics (NASDAQ:CYTH) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.16) by 31.25 percent. This is a 36.36 percent increase over losses of $(0.33) per share
08-15 21:03